In the present study, we investigated the prognostic and predictive power of a novel inflammation-based system—the Mesothelioma Systemic Inflammation Score, a product of NLR, PLR, CRP, and fibrinogen—in a large cohort of pleural mesothelioma patients treated in a high-volume center. This evidence concerns the gene CRP and mesothelioma.